Gene sequencing device maker pulls in $50.8M in financing

A private placement of ordinary shares brought Oxford Nanopore Technologies $50.8 million in new funding. Oxford will use the money to create a commercial infrastructure, increase its production capabilities, add to is intellectual property portfolio and support research and development. The firm intends to commercialize two DNA sequencing platforms this year.

View Full Article in:

Oxford Nanopore Raises $50.8M from Existing Investors - GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT